SCLN Financial Facts

Net income: 9.64M
Sales and marketing: 11.24M
See Full Income Statement

Property and equipment, net: 1.19M
Accounts receivable: 35.77M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 11/12/14 *Est. EPS Growth Rate +122.2% *Last Qtr.
Average EPS % Beat Rate +2.9% Revenue Growth Rate +9.0% *Last Qtr.
Average % Move 1-Wk after EPS +5.3% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/11/14 Q214 $0.20$0.10 +$0.10$32.5M$33.4M = Details
5/12/14 Q114 $0.10$0.08 +$0.02$26.6M$32.2M = Details
4/1/13 Q413 $0.04$0.12 -$0.08$33.1M$35.3M = Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M = Details
11/12/13 Q313 $0.18$0.15 +$0.03$35.2M$39.7M = Details
8/7/13 Q213 $0.09$0.11 -$0.02$29.81M$33.3M = Details
11/9/12 Q312 $0.20$0.21 -$0.01$40.7M$44.8M Details
8/8/12 Q212 $0.19$0.17 +$0.02$40.3M$41.98M Details